Clinical Trials

Accrual Status
Limit to SWOG Trials

1040 Results

View
Closed
Phase
SWOG Clinical Trial Number
S9910

Leukemia Centralized Reference Laboratories and Tissue Repositories, Ancillary
Research Committee(s)
Leukemia
Activated
04-15-1999
Closed
01-01-2012
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9810

A Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma
Research Committee(s)
Sarcoma
Activated
02-15-1999
Closed
08-15-2000
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
S9811

Phase II Study of Hydroxyurea for Unresectable Meningioma
Activated
11-15-1998
Closed
06-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9806

Randomized Phase II Trial of Carboplatin/Gemcitabine Followed by Paclitaxel or Cisplatin/Vinorelbine Followed by Docetaxel in Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
11-01-1998
Closed
11-15-1999
Closed
Phase
Accrual
7%
SWOG Clinical Trial Number
S9716

A Phase II Trial of Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma)
Research Committee(s)
Melanoma
Activated
10-15-1998
Closed
08-15-2000
Closed
Phase
SWOG Clinical Trial Number
S9807

Repository for Paraffin Embedded Tissues from Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Research Committee(s)
Head and Neck Cancer
Activated
09-01-1998
Closed
02-15-2004
Closed
Phase
Accrual
18%
SWOG Clinical Trial Number
S9805

Phase II Study of Tandem High Dose Melphalan Supported, by Peripheral Blood Stem Cell Support in Waldenstrom’s Macroglobulinemia (WM).
Activated
09-01-1998
Closed
05-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9717

Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer, Phase II.
Research Committee(s)
Gynecologic Cancer
Activated
08-15-1998
Closed
08-15-2000
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
S9803

The Evaluation of Gemcitabine (Gemzar®) in Resistant and Relapsing Multiple Myeloma, Phase II
Activated
08-15-1998
Closed
12-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9832

Enhancing Well-Being During Breast Cancer Recurrence
Research Committee(s)
Breast Cancer
Activated
07-15-1998
Closed
11-15-2002
Closed
Phase
Accrual
18%
SWOG Clinical Trial Number
S9624

Evaluation of Ifosfamide/Mesna for Aggressive Meningeal Tumors (Malignant Meningioma, Hemangiopericytoma and Primary Nervous System Sarcoma), Phase II Study.
Research Committee(s)
Brain Cancer
Activated
07-01-1998
Closed
10-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9718

A Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9713

A Phase II Trial of Cisplatin/Etoposide and Concurrent, Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation For Limited Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
08-01-1999
Open
Phase
SWOG Clinical Trial Number
S9808

Long Term Follow-Up Protocol: An Administrative Tool.
Research Committee(s)
Other
Activated
06-15-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9802

A Phase II Trial of Gemcitabine in Advanced Soft Tissue Sarcomas
Activated
05-01-1998
Closed
03-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9626

A Phase III Trial of Placebo Versus Megestrol Acetate 20 mg/Day Versus Megestrol Acetate 40 mg/Day as Treatment for Symptoms of Ovarian Failure in Women Treated for Breast Cancer
Activated
04-15-1998
Closed
05-01-2000
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
S9635

A Phase II Trial of 5-fluorouracil Plus 776C85 in Patients With Advanced Resistant Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-01-1998
Closed
09-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9801

Evaluation of Gemcitabine - Cisplatin Combination Chemotherapy in Esophageal Carcinoma.
Activated
04-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9720

Phase II Trial of Paclitaxel and Carboplatin with Amifostine in Advanced Recurrent or Refractory Endometrial Adenocarcinoma
Research Committee(s)
Gynecologic Cancer
Activated
02-15-1998
Closed
07-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9712

Phase II Trial of Concurrent Carboplatin/VP-16 and Radiation Followed by Paclitaxel (Taxol®) For Poor-Risk Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
02-15-1998
Closed
06-01-2000